Prestige Consumer Healthcare Inc. (NYSE:PBH - Get Free Report) insider William P'pool sold 8,987 shares of the firm's stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $81.85, for a total transaction of $735,585.95. Following the sale, the insider now directly owns 20,058 shares in the company, valued at approximately $1,641,747.30. The trade was a 30.94 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Prestige Consumer Healthcare Price Performance
NYSE PBH traded down $0.68 on Friday, reaching $82.11. The company had a trading volume of 16,810 shares, compared to its average volume of 249,609. The stock has a market capitalization of $4.06 billion, a PE ratio of 20.15, a price-to-earnings-growth ratio of 2.32 and a beta of 0.47. The firm's 50 day moving average price is $72.98 and its 200 day moving average price is $70.09. The company has a quick ratio of 2.10, a current ratio of 3.56 and a debt-to-equity ratio of 0.61. Prestige Consumer Healthcare Inc. has a 12 month low of $56.61 and a 12 month high of $83.83.
Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its earnings results on Thursday, November 7th. The company reported $1.09 earnings per share for the quarter, meeting analysts' consensus estimates of $1.09. The firm had revenue of $283.79 million during the quarter, compared to analyst estimates of $282.09 million. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. Prestige Consumer Healthcare's revenue for the quarter was down .9% compared to the same quarter last year. During the same period last year, the firm posted $1.07 earnings per share. As a group, equities analysts predict that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current year.
Wall Street Analyst Weigh In
Blackrock’s Sending THIS Crypto Higher on Purpose
From Crypto 101 Media | Ad
It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development…
YES, I WANT THE #1 CRYPTO NOW
A number of brokerages have weighed in on PBH. Jefferies Financial Group reiterated a "hold" rating and set a $76.00 target price (up from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. DA Davidson restated a "buy" rating and set a $95.00 target price on shares of Prestige Consumer Healthcare in a research note on Monday. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat.com, Prestige Consumer Healthcare presently has an average rating of "Moderate Buy" and an average price target of $94.20.
Read Our Latest Report on Prestige Consumer Healthcare
Hedge Funds Weigh In On Prestige Consumer Healthcare
A number of institutional investors and hedge funds have recently modified their holdings of PBH. SG Americas Securities LLC purchased a new stake in shares of Prestige Consumer Healthcare in the first quarter valued at $218,000. Swiss National Bank increased its holdings in Prestige Consumer Healthcare by 0.3% during the 1st quarter. Swiss National Bank now owns 97,900 shares of the company's stock worth $7,104,000 after purchasing an additional 300 shares during the period. Headlands Technologies LLC bought a new stake in shares of Prestige Consumer Healthcare in the first quarter valued at about $55,000. ProShare Advisors LLC raised its holdings in shares of Prestige Consumer Healthcare by 7.4% in the 1st quarter. ProShare Advisors LLC now owns 10,042 shares of the company's stock valued at $729,000 after purchasing an additional 691 shares in the last quarter. Finally, Entropy Technologies LP purchased a new stake in Prestige Consumer Healthcare during the first quarter worth $383,000. Hedge funds and other institutional investors own 99.95% of the company's stock.
About Prestige Consumer Healthcare
(
Get Free Report)
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
